HER2 expression and efficacy of T-DM1

Breast Cancer Res. 2014 Dec 3;16(6):478. doi: 10.1186/s13058-014-0478-7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Erb-b2 Receptor Tyrosine Kinases / genetics*
  • Female
  • Humans
  • Maytansine / analogs & derivatives*
  • Taxoids / therapeutic use*

Substances

  • Antibodies, Monoclonal, Humanized
  • Maytansine
  • Erb-b2 Receptor Tyrosine Kinases
  • Taxoids